Australia's largest stock trading and investment forum Australia's #1 stock forum

DXB

Click for more information

3.95%

39.5¢ dimerix limited

Ann: DMX-200 Competitive Position Further Enhanced, page-61

First 61 Last

Share
Profile

Follow
HS2912

47 Posts.

11

26/03/21

07:16

Post #: 52053216
Share

Originally posted by Owl vs Fox: ↑

GMP is required for all human clinical trials & manufacture of drugs! DXB already have upscaled GMP & FDA approved manufacturing of DMX-200 in the USA for COVID-19 trials via an approved Pharma for patient needs & not considering upcoming renal disease trials, you are potentially looking at dosing for 1000 patients, just to cover the initial 200 in REMAP CAP & move to Ph3, then 600 in CLARITY-2.0, and then all the patients that remain on Special Access Scheme via scripts from their treating Physicians (coming up to>4 years now for some patients from Ph2A, these ones were sicker, you are looking at a potential diversion from dialysis right here. The FDA requirements for approval were started way back in 2019 for packaging, shelf life stability, all those things required were done prior to Ph2. TGA obviously happy with SAS earlier on & not many drugs are given the ok this way, there has to be very good evidence. That data is sitting there now for PH3 & open label.

Not sure what you are talking about @HS2912??

GLTAH

Expand

This is an in vitro study, hence no requirements. Obviously different story if it was in humans...

DXB Price at posting: 26.5¢ Sentiment: Buy Disclosure: Held
2 Upvote

0 Great analysis

Reply

Top Stories

OCC

Orthocell wins first international approval for nerve repair product

LMS

Litchfield boosts its copper, base and precious metals footprint in the NT with acquisitions

WAF

West African Res jumps on claim mine safe under Burkina Faso's junta; HotCopper ponders Russia

DRO

Droneshield shares move up on $13.5M US govt contract

TMK

TMK Energy kicks off drilling for new pilot wells in Mongolia's vastly underexplored Gobi

There are more pages in this discussion • 6 more messages in this thread...

First 61 Last

Add DXB (ASX) to my watchlist

(20min delay)
Last 39.5¢		Change 0.015(3.95%)		Mkt cap ! $220.0M

Open	High	Low	Value	Volume
38.0¢	40.5¢	37.0¢	$863.2K	2.230M

Buyers (Bids)

No.	Vol.	Price($)
2	56796	39.0¢

Sellers (Offers)

Price($)	Vol.	No.
39.5¢	15592	1

View Market Depth

No.	Vol.	Price($)
2	56796	0.390
3	71796	0.385
5	81657	0.380
3	195687	0.375
14	403336	0.370

Price($)	Vol.	No.
0.395	15592	1
0.400	56565	4
0.405	45762	4
0.410	524421	8
0.415	44000	2

Last trade - 15.59pm 08/10/2024 (20 minute delay)

DXB (ASX) Chart